Harvard Bioscience stem cells in Russian tracheal transplants

(Nasdaq:HBIO), a life sciences tools company, says the first two successful stem cells laryngotracheal transplants have been completed in Russia, using the company’s specially designed bioreactor to grow the stem cells, which were taken from the patients’ bone marrow.

View the original article here: Harvard Bioscience stem cells in Russian tracheal transplants – The Business Journal

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend